Renascience Inc. (TYO:4889)
Japan · Delayed Price · Currency is JPY 1,469.00
+14.00 (0.96%)
At close: Feb 6, 2026
Renascience Market Cap
Renascience has a market cap or net worth of 19.46 billion as of February 6, 2026. Its market cap has increased by 231.43% in one year.
Market Cap
19.46B
Enterprise Value
17.90B
Revenue
87.00M
Ranking
n/a
PE Ratio
572.48
Stock Price
1,469.00
Market Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 19.46B, an increase of 92.07%. That is a compound annual growth rate of 16.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 19.28B | 4.84% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 26.14B |
| AnGes | 22.95B |
| Japan Tissue Engineering | 21.85B |
| StemRIM | 17.61B |
| CanBas | 17.37B |
| ReproCELL | 15.06B |
| Immuno-Biological Laboratories | 14.11B |
| Kubota Pharmaceutical Holdings | 12.69B |